Search

Your search keyword '"Fourié, Toscane"' showing total 28 results
Start Over Author "Fourié, Toscane"
28 results on '"Fourié, Toscane"'

1. SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave

Author

Pouquet, Marie, Decarreaux, Dorine, Di Domenico, Laura, Sabbatini, Chiara E., Prévot-Monsacre, Pol, Fourié, Toscane, Villarroel, Paola Mariela Saba, Priet, Stephane, Blanché, Hélène, Sebaoun, Jean-Marc, Deleuze, Jean-François, Turbelin, Clément, Rossignol, Louise, Werner, Andréas, Kochert, Fabienne, Grosgogeat, Brigitte, Rabiega, Pascaline, Laupie, Julien, Abraham, Nathalie, Noël, Harold, van der Werf, Sylvie, Colizza, Vittoria, Carrat, Fabrice, Charrel, Remi, de Lamballerie, Xavier, Blanchon, Thierry, and Falchi, Alessandra

Published
2024
Full Text
View/download PDF

2. Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancer

Author

Couderc, Anne-Laure, Ninove, Laetitia, Nouguerède, Emilie, Rey, Dominique, Rebroin, Marina, Daumas, Aurélie, Tomasini, Pascale, Greillier, Laurent, Salas, Sebastien, Duffaud, Florence, Dahan, Laetitia, Duluc, Muriel, Garcia, Marie-Eve, Pluvy, Johan, Chaléat, Solène, Farnault, Laure, Venton, Geoffroy, Fourié, Toscane, Nurtop, Elif, de Lamballerie, Xavier, Villani, Patrick, Charrel, Remi, and Correard, Florian

Published
2022
Full Text
View/download PDF

5. Presence of specific SARS-COV2 antibodies in hemodialysis patients and their caregivers after the first wave of COVID-19

Author

Robert, Thomas, Lano, Guillaume, Resseguier, Noémie, Bobot, Mickaël, Bouchouareb, Dammar, Burtey, Stéphane, de Lamballerie, Xavier, Dhorne, Jean, Dussol, Bertrand, Duval, Ariane, Faraut, Julien, Fourié, Toscane, Giaime, Philippe, Hallah, Mourad, Jaubert, Dominique, Jéhel, Océane, Legris, Tristan, Liotatis, Stéphane, Moal, Valérie, Ninove, Laetitia, Pedinielli, Nathalie, Pelletier, Marion, Romeu-Giannoli, Manon, Saba, Mariela, Sallée, Marion, Samson, Laurent, Saveanu, Adriana, Scarfoglière, Violaine, Sebahoun, Pascale, Vial, Romain, Von Kotze, Clarissa, Brunet, Philippe, Lebrun, Gaëtan, Bataille, Stanislas, and Jourde-Chiche, Noémie

Published
2022
Full Text
View/download PDF

7. Eight Months of Serological Follow-Up of Anti-SARS-CoV-2 Antibodies in France: A Study among an Adult Population

Author

Decarreaux, Dorine, primary, Sevila, Julie, additional, Masse, Shirley, additional, Capai, Lisandru, additional, Fourié, Toscane, additional, Villarroel, Paola Mariela Saba, additional, Amroun, Abdennour, additional, Nurtop, Elif, additional, Vareille, Matthieu, additional, Blanchon, Thierry, additional, de Lamballerie, Xavier, additional, Charrel, Remi, additional, and Falchi, Alessandra, additional

Published
2022
Full Text
View/download PDF

8. Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France

Author

Decarreaux, Dorine, primary, Pouquet, Marie, additional, Souty, Cecile, additional, Vilcu, Ana-Maria, additional, Prévot-Monsacre, Pol, additional, Fourié, Toscane, additional, Villarroel, Paola Mariela Saba, additional, Priet, Stephane, additional, Blanché, Hélène, additional, Sebaoun, Jean-Marc, additional, Deleuze, Jean-François, additional, Turbelin, Clément, additional, Werner, Andréas, additional, Kochert, Fabienne, additional, Grosgogeat, Brigitte, additional, Rabiega, Pascaline, additional, Laupie, Julien, additional, Abraham, Nathalie, additional, Guerrisi, Caroline, additional, Noël, Harold, additional, Van der Werf, Sylvie, additional, Carrat, Fabrice, additional, Hanslik, Thomas, additional, Charrel, Remi, additional, De Lamballerie, Xavier, additional, Blanchon, Thierry, additional, and Falchi, Alessandra, additional

Published
2022
Full Text
View/download PDF

9. A simple reverse genetics method to generate recombinant coronaviruses

Author

Mélade, Julien, primary, Piorkowski, Géraldine, additional, Touret, Franck, additional, Fourié, Toscane, additional, Driouich, Jean‐Sélim, additional, Cochin, Maxime, additional, Bouzidi, Hawa Sophia, additional, Coutard, Bruno, additional, Nougairède, Antoine, additional, and Lamballerie, Xavier, additional

Published
2022
Full Text
View/download PDF

10. A Cross-Sectional Study of Exposure Factors Associated with Seropositivity for SARS-CoV-2 Antibodies during the Second Epidemic Wave among a Sample of the University of Corsica (France)

Author

Decarreaux, Dorine, primary, Sevila, Julie, additional, Masse, Shirley, additional, Capai, Lisandru, additional, Fourié, Toscane, additional, Saba Villarroel, Paola Mariela, additional, Amroun, Abdennour, additional, Nurtop, Elif, additional, Vareille, Matthieu, additional, Pouquet, Marie, additional, Blanchon, Thierry, additional, de Lamballerie, Xavier, additional, Charrel, Rémi, additional, and Falchi, Alessandra, additional

Published
2022
Full Text
View/download PDF

13. Humoral response after SARS-CoV-2 vaccination in patients undergoing maintenance haemodialysis: loss of immunity, third dose and non-responders

Author

Robert, Thomas, primary, Lano, Guillaume, additional, Giot, Matthieu, additional, Fourié, Toscane, additional, de Lamballeri, Xavier, additional, Jehel, Océane, additional, Bouchouareb, Dammar, additional, Brunet, Philippe, additional, Ninove, Laetitia, additional, and Burtey, Stéphane, additional

Published
2021
Full Text
View/download PDF

14. Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy

Author

Rico, Audrey, primary, Ninove, Laetitia, additional, Maarouf, Adil, additional, Boutiere, Clémence, additional, Durozard, Pierre, additional, Demortiere, Sarah, additional, Saba Villarroel, Paola Mariela, additional, Amroun, Abdennour, additional, Fourié, Toscane, additional, de Lamballerie, Xavier, additional, Pelletier, Jean, additional, and Audoin, Bertrand, additional

Published
2021
Full Text
View/download PDF

15. Corrigendum to: Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study

Author

Carrat, Fabrice, primary, de Lamballerie, Xavier, additional, Rahib, Delphine, additional, Blanché, Hélène, additional, Lapidus, Nathanael, additional, Artaud, Fanny, additional, Kab, Sofiane, additional, Renuy, Adeline, additional, Szabo de Edelenyi, Fabien, additional, Meyer, Laurence, additional, Lydié, Nathalie, additional, Charles, Marie-Aline, additional, Ancel, Pierre-Yves, additional, Jusot, Florence, additional, Rouquette, Alexandra, additional, Priet, Stéphane, additional, Saba Villarroel, Paola Mariela, additional, Fourié, Toscane, additional, Lusivika-Nzinga, Clovis, additional, Nicol, Jérôme, additional, Legot, Stephane, additional, Druesne-Pecollo, Nathalie, additional, Esseddik, Younes, additional, Lai, Cindy, additional, Gagliolo, Jean-Marie, additional, Deleuze, Jean-François, additional, Bajos, Nathalie, additional, Severi, Gianluca, additional, Touvier, Mathilde, additional, and Zins, Marie, additional

Published
2021
Full Text
View/download PDF

16. Impact of the Second Epidemic Wave of SARS-CoV-2: Increased Exposure of Young People

Author

Capai, Lisandru, primary, Masse, Shirley, additional, Fourié, Toscane, additional, Decarreaux, Dorine, additional, Canarelli, Jean, additional, Simeoni, Marie-Helene, additional, Amroun, Abdennour, additional, Mohammed-Ali, Souand, additional, Saba Villarroel, Paola Mariela, additional, Lamballerie, Xavier de, additional, Charrel, Rémi, additional, and Falchi, Alessandra, additional

Published
2021
Full Text
View/download PDF

17. Spike and neutralizing antibodies response to COVID-19 vaccination in haemodialysis patients

Author

Giot, Matthieu, primary, Fourié, Toscane, additional, Lano, Guillaume, additional, Villarroel, Paola Mariela Saba, additional, Lamballeri, Xavier de, additional, Gully, Marion, additional, Samson, Laurent, additional, Farault, Julien, additional, Bouchouareb, Dammar, additional, Jehel, Océane, additional, Brunet, Philippe, additional, Jourde-Chiche, Noémie, additional, Ninove, Laetitia, additional, and Robert, Thomas, additional

Published
2021
Full Text
View/download PDF

23. Seroprevalence of SARS-CoV-2 Among Adults in Three Regions of France Following the Lockdown and Associated Risk Factors: A Multicohort Study

Author

Carrat, Fabrice, primary, de Lamballerie, Xavier, additional, Rahib, Delphine, additional, Blanché, Hélène, additional, Lapidus, Nathanael, additional, Artaud, Fanny, additional, Kab, Sofiane, additional, Renuy, Adeline, additional, de Edelenyi, Fabien Szabo, additional, Meyer, Laurence, additional, Lydié, Nathalie, additional, Charles, Marie-Aline, additional, Ancel, Pierre-Yves, additional, Jusot, Florence, additional, Rouquette, Alexandra, additional, Priet, Stéphane, additional, Villarroel, Paola Mariela Saba, additional, Fourié, Toscane, additional, Lusivika-Nzinga, Clovis, additional, Nicol, Jerome, additional, Legot, Stephane, additional, Druesne-Pecollo, Nathalie, additional, Esseddik, Younes, additional, Lai, Cindy, additional, Gagliolo, Jean-Marie, additional, Deleuze, Jean-François, additional, Bajos, Nathalie, additional, Severi, Gianluca, additional, Touvier, Mathilde, additional, Zins, Marie, additional, and Groups, SAPRIS and SAPRIS-SERO Study, additional

Published
2020
Full Text
View/download PDF

24. Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study.

Author

Carrat, Fabrice, Lamballerie, Xavier de, Rahib, Delphine, Blanché, Hélène, Lapidus, Nathanael, Artaud, Fanny, Kab, Sofiane, Renuy, Adeline, Edelenyi, Fabien Szabo de, Meyer, Laurence, Lydié, Nathalie, Charles, Marie-Aline, Ancel, Pierre-Yves, Jusot, Florence, Rouquette, Alexandra, Priet, Stéphane, Villarroel, Paola Mariela Saba, Fourié, Toscane, Lusivika-Nzinga, Clovis, and Nicol, Jérôme

Subjects
ADULTS, SARS-CoV-2, STAY-at-home orders, COVID-19, SEROCONVERSION
Abstract

Background: We aimed to estimate the seropositivity to anti-SARS-CoV-2 antibodies in May-June 2020 after the first lockdown period in adults living in three regions in France and to identify the associated risk factors.Methods: Between 4 May 2020 and 23 June 2020, 16 000 participants in a survey on COVID-19 from an existing consortium of three general adult population cohorts living in the Ile-de-France (IDF) or Grand Est (GE) (two regions with high rate of COVID-19) or in the Nouvelle-Aquitaine (NA) (with a low rate) were randomly selected to take a dried-blood spot for anti-SARS-CoV-2 antibodies assessment with three different serological methods (ClinicalTrial Identifier #NCT04392388). The primary outcome was a positive anti-SARS-CoV-2 ELISA IgG result against the spike protein of the virus (ELISA-S). Estimates were adjusted using sampling weights and post-stratification methods. Multiple imputation was used to infer the cumulative incidence of SARS-CoV-2 infection with adjustments for imperfect tests accuracies.Results: The analysis included 14 628 participants, 983 with a positive ELISA-S. The weighted estimates of seropositivity and cumulative incidence were 10.0% [95% confidence interval (CI): 9.1%, 10.9%] and 11.4% (95% CI: 10.1%, 12.8%) in IDF, 9.0% (95% CI: 7.7%, 10.2%) and 9.8% (95% CI: 8.1%, 11.8%) in GE and 3.1% (95% CI: 2.4%, 3.7%) and 2.9% (95% CI: 2.1%, 3.8%) in NA, respectively. Seropositivity was higher in younger participants [odds ratio (OR) = 1.84 (95% CI: 1.79, 6.09) in <40 vs 50-60 years old and OR = 0.56 (95% CI: 0.42, 0.74) in ≥70 vs 50-60 years old)] and when at least one child or adolescent lived in the same household [OR = 1.30 (95% CI: 1.11, 1.53)] and was lower in smokers compared with non-smokers [OR = 0.71 (95% CI: 0.57, 0.49)].Conclusions: Seropositivity to anti-SARS-CoV-2 antibodies in the French adult population was ≤10% after the first wave. Modifiable and non-modifiable risk factors were identified. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

25. Tracking Rift Valley fever: From Mali to Europe and other countries, 2016

Author

Tong, Christelle, primary, Javelle, Emilie, additional, Grard, Gilda, additional, Dia, Aissata, additional, Lacrosse, Constance, additional, Fourié, Toscane, additional, Gravier, Patrick, additional, Watier-Grillot, Stéphanie, additional, Lancelot, Renaud, additional, Letourneur, Franck, additional, Comby, Frédéric, additional, Grau, Martin, additional, Cassou, Lionel, additional, Meynard, Jean-Baptiste, additional, Briolant, Sébastien, additional, Leparc-Goffart, Isabelle, additional, and Pommier de Santi, Vincent, additional

Published
2019
Full Text
View/download PDF

28. Long-Term Infectivity of Chikungunya Virus Stored in the Dark at 4°C.

Author

Pezzi L, Py O, Gilles M, Saba Villarroel PM, Diarra I, Fourié T, Gould EA, Gallian P, and de Lamballerie X

Subjects
Cell Line, Darkness, RNA, Viral, Chikungunya virus genetics, Cold Temperature, Specimen Handling
Abstract

We call into question the established dogma that viruses with envelopes and RNA genomes have limited stability by demonstrating the staggering long-term viability, ∼2 years, of chikungunya virus when stored in liquid environments at +4°C in the dark. We contend that our understanding of the infectivity of a variety of enveloped viruses requires a new approach to identify under standardized conditions the primary determinants of their viability.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results